Canary Medical and NanoHive Announce Smart Spinal Cage Partnership
  • News
  • North America

Canary Medical and NanoHive Announce Smart Spinal Cage Partnership

The collaboration aims to integrate sensing technology into 3D printed implants for data-driven care.

4/20/2026
Ghita Khalfaoui
Back to News

Canary Medical and NanoHive Medical have announced an exclusive partnership to develop a new generation of smart spinal implants. This collaboration will integrate Canary's proven sensing technology with NanoHive's advanced 3D printed spinal cage designs. The initiative aims to revolutionize spinal care by providing real-time, objective data to improve patient recovery and surgical outcomes.


Addressing Unmet Needs in Spinal Fusion

Spinal fusion procedures currently face significant challenges, with many patients reporting dissatisfaction post-surgery due to persistent pain and functional limitations. Current monitoring relies on periodic imaging and patient feedback, which only provide limited, episodic insights. This uncertainty around fusion progression is a key issue the new technology seeks to address.

The new smart spinal cages are designed to overcome these limitations by embedding sensing technology directly within the implant. This innovation will generate continuous, objective data on fusion progression, mobility, and patient activity levels. Such detailed information enables earlier identification of recovery issues and supports more personalized, data-informed interventions.

A Strategic Combination of Technologies

Canary Medical brings its pioneering active implantable platform and AI-driven analytics to the partnership. The company has already achieved success with its FDA-cleared smart knee platform, which collects mobility data from within the body. This collaboration extends their validated architecture to address significant unmet needs within the spinal care market.

NanoHive Medical contributes its expertise in 3D printed spinal implants using its proprietary Hive™ Soft Titanium® technology. The company is known for its advanced engineering and porous designs that promote bone integration and stability. This structure is uniquely suited to accommodate Canary's sensing technology without compromising the implant's primary function.

This partnership creates a powerful synergy, allowing NanoHive to accelerate its entry into intelligent implants while reducing development risks. For Canary, NanoHive's design provides an ideal platform for its smart technology, as noted by CEO Dr. Bill Hunter. Together, they aim to redefine the capabilities of spinal implants for surgeons and patients.

Market Impact and Future Outlook

The collaboration targets the substantial global spinal fusion market, currently estimated at between $6 and $9 billion. Driven by an aging population and rising rates of degenerative spine disease, this market is projected to grow significantly. Industry forecasts predict it will exceed $13 billion over the next decade, presenting a major opportunity.

The companies believe these data-enabled spinal cages can establish a new premium segment within this large market. This aligns with the broader healthcare industry's shift towards measurable outcomes and value-based care models. The goal is to provide a tool that generates meaningful clinical data to guide better treatment decisions.

Joint development efforts have already commenced, with an immediate focus on design integration and engineering validation. The teams are also working to define key clinical applications for the new smart implant technology. Further announcements on development milestones and future clinical plans are expected as the project progresses.


The strategic alliance between Canary Medical and NanoHive Medical represents a significant advancement in orthopedic technology. By combining implantable sensors with advanced spinal cage design, the partnership is poised to transform post-operative care. This move toward data-driven, intelligent implants promises to enhance clinical insights, personalize rehabilitation, and ultimately improve patient outcomes.